Provides infusion pumps and supplies for cancer treatments.
Jun 2026Revenue $143M/yrExpenses $130M/yr
No trend
Figures by year
Is InfuSystem Holdings profitable?
Yes. In the 12 months to Jun 2026, revenue was $143M and expenses $130M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $143M | $132M | $11.9M |
| Dec 2024 | $135M | $128M | $6.89M |
| Dec 2023 | $126M | $122M | $4.09M |
| Dec 2022 | $110M | $108M | $1.65M |
| Dec 2021 | $102M | $99.6M | $2.82M |
| Dec 2020 | $97.4M | $88.6M | $8.83M |
| Dec 2019 | $81.1M | $77.6M | $3.52M |
| Dec 2018 | $67.1M | $66.7M | $415K |
| Dec 2017 | $71.1M | $74.9M | −$3.81M |
| Dec 2016 | $70.5M | $69.5M | $974K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.